Corpay Financials
Corpay (CPAY) reported $4.5B in revenue for fiscal year 2025, up 13.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Corpay's high-margin, low-capex model still throws off cash, but balance-sheet expansion is reducing return efficiency.
From FY2023 to FY2025, operating margin stayed near44.0% while ROA fell to4.1% , showing that sales economics held up even as a much larger asset base earned less per dollar invested. Because assets grew faster than revenue and goodwill plus debt both stepped up, recent scale looks more financed and acquired than internally built.
FY2025 free cash flow was
A current ratio below 1.0x alongside long-term debt of
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Corpay's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Corpay has an operating margin of 44.0%, meaning the company retains $44 of operating profit per $100 of revenue. This strong profitability earns a score of 99/100, reflecting efficient cost management and pricing power. This is down from 45.0% the prior year.
Corpay's revenue grew 13.9% year-over-year to $4.5B, a solid pace of expansion. This earns a growth score of 64/100.
Corpay has elevated debt relative to equity (D/E of 2.58), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 19/100, reflecting increased financial risk.
Corpay's current ratio of 0.98 is below the typical benchmark, resulting in a score of 18/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Corpay converts 28.7% of revenue into free cash flow ($1.3B). This strong cash generation earns a score of 97/100.
Corpay earns a strong 27.6% return on equity (ROE), meaning it generates $28 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 89/100. This is down from 32.2% the prior year.
Corpay scores 1.68, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Corpay passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Corpay generates $1.40 in operating cash flow ($1.5B OCF vs $1.1B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Corpay earns $4.94 in operating income for every $1 of interest expense ($2.0B vs $403.8M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Corpay generated $4.5B in revenue in fiscal year 2025. This represents an increase of 13.9% from the prior year.
Corpay's EBITDA was $2.4B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 11.7% from the prior year.
Corpay reported $1.1B in net income in fiscal year 2025. This represents an increase of 6.6% from the prior year.
Corpay earned $15.03 per diluted share (EPS) in fiscal year 2025. This represents an increase of 7.6% from the prior year.
Cash & Balance Sheet
Corpay generated $1.3B in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 26.4% from the prior year.
Corpay held $2.4B in cash against $10.0B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Corpay's operating margin was 44.0% in fiscal year 2025, reflecting core business profitability. This is down 0.9 percentage points from the prior year.
Corpay's net profit margin was 23.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.6 percentage points from the prior year.
Corpay's ROE was 27.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 4.6 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
Corpay spent $782.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 39.2% from the prior year.
Corpay invested $200.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 14.6% from the prior year.
Not reported for fiscal year 2025.
CPAY Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.0B | $4.5B+13.9% | $4.0B+5.8% | $3.8B+9.6% | $3.4B+20.9% | $2.8B+18.6% | $2.4B-9.8% | $2.6B+8.8% | $2.4B+8.2% | $2.2B+22.8% | $1.8B+7.6% | $1.7B+42.0% | $1.2B+34.0% | $895.2M+26.5% | $707.5M+36.2% | $519.6M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $96.8M+5.7% | $91.6M+8.9% | $84.1M+537.1% | $13.2M+85.9% | $7.1M+51.1% | $4.7M | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $2.2B+23.7% | $1.7B+7.5% | $1.6B+36.5% | $1.2B+33.6% | $888.1M+26.4% | $702.8M | N/A |
| SG&A Expenses | $826.5M | $733.0M+18.8% | $616.9M+2.2% | $603.4M+3.3% | $584.1M+20.2% | $485.8M+29.7% | $374.7M-8.0% | $407.2M+4.6% | $389.2M+0.4% | $387.7M+36.7% | $283.6M-4.7% | $297.7M+44.5% | $206.0M+44.8% | $142.3M+29.2% | $110.1M+29.9% | $84.8M |
| Operating Income | $2.2B | $2.0B+11.6% | $1.8B+7.9% | $1.7B+14.5% | $1.4B+16.4% | $1.2B+27.8% | $972.3M-21.0% | $1.2B+12.9% | $1.1B+23.4% | $883.8M+17.2% | $754.2M+13.0% | $667.5M+18.1% | $565.4M+34.4% | $420.6M+29.5% | $324.9M+43.6% | $226.3M |
| Interest Expense | $437.9M | $403.8M+5.4% | $383.0M+9.9% | $348.6M+111.7% | $164.7M+244.8% | -$113.7M+12.4% | -$129.8M+13.5% | -$150.0M-8.3% | -$138.5M-29.3% | -$107.1M-49.0% | -$71.9M-0.8% | -$71.3M-147.2% | -$28.9M-75.3% | -$16.5M-226.5% | $13.0M-2.7% | $13.4M |
| Income Tax | $521.3M | $469.7M+23.2% | $381.4M+11.2% | $343.1M+6.8% | $321.3M+19.3% | $269.3M+51.0% | $178.3M-2.4% | $182.7M-35.6% | $283.6M+84.9% | $153.4M-19.5% | $190.5M+9.8% | $173.6M+20.3% | $144.2M+21.1% | $119.1M+25.9% | $94.6M+48.9% | $63.5M |
| Net Income | $1.1B | $1.1B+6.6% | $1.0B+2.2% | $982.0M+2.9% | $954.0M+13.7% | $839.0M+19.1% | $704.2M-21.3% | $895.1M+10.3% | $811.5M+9.6% | $740.2M+63.6% | $452.4M+24.8% | $362.4M-1.7% | $368.7M+29.6% | $284.5M+31.6% | $216.2M+46.7% | $147.3M |
| EPS (Diluted) | — | $15.03+7.6% | $13.97+5.8% | $13.20+6.3% | $12.42+24.3% | $9.99+23.0% | $8.12-18.3% | $9.94+12.8% | $8.81+11.4% | $7.91+66.5% | $4.75+23.4% | $3.85-9.2% | $4.24+26.2% | $3.36+33.3% | $2.52+43.2% | $1.76 |
Not reported in any period shown, so not listed: R&D Expenses.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CPAY Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $26.4B+47.1% | $18.0B+16.0% | $15.5B+9.8% | $14.1B+5.1% | $13.4B+19.7% | $11.2B-8.6% | $12.2B+9.3% | $11.2B-1.0% | $11.3B+17.6% | $9.6B+22.0% | $7.9B-7.4% | $8.5B+116.8% | $3.9B+44.5% | $2.7B+15.9% | $2.3B |
| Current Assets | $14.0B+60.9% | $8.7B+22.5% | $7.1B+16.0% | $6.1B+11.3% | $5.5B+38.7% | $4.0B-14.3% | $4.6B+19.2% | $3.9B+9.2% | $3.5B+40.4% | $2.5B+30.0% | $1.9B-9.0% | $2.1B+57.9% | $1.4B+13.2% | $1.2B+6.3% | $1.1B |
| Cash & Equivalents | $2.4B+55.0% | $1.6B+11.8% | $1.4B-3.2% | $1.4B-5.6% | $1.5B+62.6% | $934.9M-26.5% | $1.3B+23.3% | $1.0B+12.9% | $913.6M+92.3% | $475.0M+6.2% | $447.2M-6.3% | $477.1M+41.1% | $338.1M+19.2% | $283.6M-0.5% | $285.2M |
| Accounts Receivable | $2.1B+2.6% | $2.1B-3.3% | $2.2B+4.7% | $2.1B+15.1% | $1.8B+31.2% | $1.4B-12.9% | $1.6B+10.0% | $1.4B+0.4% | $1.4B+18.1% | $1.2B+88.1% | $639.0M-5.2% | $673.8M+17.5% | $573.4M+9.1% | $525.4M+9.1% | $481.8M |
| Goodwill | $7.6B+26.4% | $6.0B+6.0% | $5.6B+8.5% | $5.2B+2.4% | $5.1B+7.6% | $4.7B-2.4% | $4.8B+6.4% | $4.5B-3.7% | $4.7B+12.4% | $4.2B+18.3% | $3.5B-4.5% | $3.7B+141.8% | $1.5B+65.7% | $926.6M+21.8% | $760.7M |
| Total Liabilities | $22.5B+51.8% | $14.8B+21.7% | $12.2B+5.6% | $11.5B+9.6% | $10.5B+34.4% | $7.8B-8.2% | $8.5B+8.6% | $7.9B+2.9% | $7.6B+16.8% | $6.5B+29.3% | $5.1B-14.3% | $5.9B+118.0% | $2.7B+49.8% | $1.8B+17.6% | $1.5B |
| Current Liabilities | $14.3B+64.2% | $8.7B+27.6% | $6.8B+12.9% | $6.0B+14.2% | $5.3B+33.3% | $4.0B-11.1% | $4.5B-0.7% | $4.5B+9.8% | $4.1B+24.2% | $3.3B+46.7% | $2.2B-22.4% | $2.9B+51.7% | $1.9B+67.1% | $1.1B+1.4% | $1.1B |
| Long-Term Debt | $10.0B+25.1% | $8.0B+18.9% | $6.7B-4.5% | $7.0B+17.7% | $6.0B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $474.9M-2.1% | $485.2M+74.3% | $278.4M |
| Total Equity | $3.9B+24.4% | $3.1B-4.9% | $3.3B+29.2% | $2.5B-11.3% | $2.9B-14.6% | $3.4B-9.6% | $3.7B+11.1% | $3.3B-9.1% | $3.7B+19.2% | $3.1B+9.0% | $2.8B+8.1% | $2.6B+114.0% | $1.2B+33.9% | $913.8M+12.6% | $811.4M |
| Retained Earnings | $10.3B+11.6% | $9.2B+12.3% | $8.2B+13.6% | $7.2B+15.3% | $6.3B+15.5% | $5.4B+14.9% | $4.7B+23.4% | $3.8B+29.0% | $3.0B+33.4% | $2.2B+25.6% | $1.8B+25.8% | $1.4B+35.6% | $1.0B+37.9% | $750.7M+40.4% | $534.5M |
Not reported in any period shown, so not listed: Inventory.
CPAY Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.5B-22.7% | $1.9B-7.6% | $2.1B+178.4% | $754.8M-36.9% | $1.2B-18.7% | $1.5B+26.7% | $1.2B+28.6% | $903.4M+32.8% | $680.1M-4.0% | $708.2M-6.1% | $754.6M+24.0% | $608.3M+61.9% | $375.7M+177.3% | $135.5M-51.6% | $279.6M |
| Capital Expenditures | $208.9M | $200.8M+14.6% | $175.2M+13.9% | $153.8M+1.6% | $151.4M+35.8% | $111.5M+42.2% | $78.4M+4.3% | $75.2M-7.6% | $81.4M+16.1% | $70.1M+18.8% | $59.0M+40.9% | $41.9M+54.7% | $27.1M+30.2% | $20.8M+8.8% | $19.1M+42.0% | $13.5M |
| Free Cash Flow | $1.6B | $1.3B-26.4% | $1.8B-9.3% | $1.9B+222.7% | $603.4M-44.4% | $1.1B-22.1% | $1.4B+28.3% | $1.1B+32.2% | $822.0M+34.8% | $610.0M-6.0% | $649.2M-8.9% | $712.7M+22.6% | $581.3M+63.8% | $354.9M+205.0% | $116.3M-56.3% | $266.2M |
| Investing Cash Flow | $1.8B | $1.2B+252.0% | -$807.5M-112.1% | -$380.7M-3.4% | -$368.3M+48.6% | -$715.9M-573.8% | -$106.2M+79.7% | -$523.7M-1893.5% | -$26.3M+94.7% | -$497.8M+64.2% | -$1.4B-1297.8% | -$99.4M+96.2% | -$2.6B-246.3% | -$749.1M-257.5% | -$209.6M+39.6% | -$347.2M |
| Financing Cash Flow | $1.1B | $1.6B+285.6% | $405.0M+145.1% | -$898.2M-188.6% | -$311.2M-190.5% | $343.9M+124.3% | -$1.4B-356.8% | -$310.2M+46.3% | -$577.8M-329.3% | $251.9M-66.6% | $754.0M+216.3% | -$648.1M-130.0% | $2.2B+396.2% | $435.7M+602.9% | $62.0M-73.8% | $236.2M |
| Share Buybacks | $1.8B | $782.8M-39.2% | $1.3B+87.5% | $686.9M-51.1% | $1.4B+3.6% | $1.4B+59.5% | $849.9M+22.3% | $694.9M-27.5% | $958.7M+138.2% | $402.4M+114.4% | $187.7M | $0 | $0 | N/A | $200.0M+45046.7% | $443K |
Not reported in any period shown, so not listed: Dividends Paid.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CPAY Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 95.7%+0.7pp | 95.0%-0.1pp | 95.1%-3.8pp | 98.9%-0.3pp | 99.2%-0.1pp | 99.3% | N/A |
| Operating Margin | 44.0%-0.9pp | 45.0%+0.9pp | 44.1%+1.9pp | 42.2%-1.6pp | 43.9%+3.2pp | 40.7%-5.8pp | 46.5%+1.7pp | 44.8%+5.5pp | 39.3%-1.9pp | 41.2%+2.0pp | 39.2%-7.9pp | 47.1%+0.2pp | 47.0%+1.1pp | 45.9%+2.4pp | 43.6% |
| Net Margin | 23.6%-1.6pp | 25.3%-0.9pp | 26.1%-1.7pp | 27.8%-1.8pp | 29.6%+0.1pp | 29.5%-4.3pp | 33.8%+0.4pp | 33.4%+0.5pp | 32.9%+8.2pp | 24.7%+3.4pp | 21.3%-9.5pp | 30.7%-1.0pp | 31.8%+1.2pp | 30.6%+2.2pp | 28.4% |
| Return on Equity | 27.6%-4.6pp | 32.2%+2.2pp | 29.9%-7.6pp | 37.5%+8.3pp | 29.3%+8.3pp | 21.0%-3.1pp | 24.1%-0.2pp | 24.3%+4.2pp | 20.1%+5.5pp | 14.7%+1.9pp | 12.8%-1.3pp | 14.1%-9.2pp | 23.3%-0.4pp | 23.7%+5.5pp | 18.2% |
| Return on Assets | 4.0%-1.5pp | 5.6%-0.8pp | 6.3%-0.4pp | 6.8%+0.5pp | 6.3%0.0pp | 6.3%-1.0pp | 7.3%+0.1pp | 7.2%+0.7pp | 6.5%+1.8pp | 4.7%+0.1pp | 4.6%+0.3pp | 4.3%-2.9pp | 7.2%-0.7pp | 7.9%+1.7pp | 6.3% |
| Current Ratio | 0.980.0x | 1.000.0x | 1.040.0x | 1.010.0x | 1.040.0x | 1.000.0x | 1.03+0.2x | 0.860.0x | 0.87+0.1x | 0.77-0.1x | 0.87+0.1x | 0.740.0x | 0.71-0.3x | 1.050.0x | 1.00 |
| Debt-to-Equity | 2.580.0x | 2.56+0.5x | 2.05-0.7x | 2.77+0.7x | 2.09-0.3x | 2.340.0x | 2.30-0.1x | 2.35+0.3x | 2.080.0x | 2.12+0.3x | 1.79-0.5x | 2.26+1.9x | 0.39-0.1x | 0.53+0.2x | 0.34 |
| FCF Margin | 28.7%-15.7pp | 44.4%-7.4pp | 51.8%+34.2pp | 17.6%-20.7pp | 38.3%-20.1pp | 58.4%+17.3pp | 41.0%+7.3pp | 33.8%+6.7pp | 27.1%-8.3pp | 35.4%-6.4pp | 41.9%-6.6pp | 48.5%+8.8pp | 39.6%+23.2pp | 16.4%-34.8pp | 51.2% |
Note: The current ratio is below 1.0 (0.98), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where Corpay Ranks
Frequently Asked Questions
What is Corpay's annual revenue?
Corpay (CPAY) reported $4.5B in total revenue for fiscal year 2025. This represents a 13.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Corpay's revenue growing?
Corpay (CPAY) revenue grew by 13.9% year-over-year, from $4.0B to $4.5B in fiscal year 2025.
Is Corpay profitable?
Yes, Corpay (CPAY) reported a net income of $1.1B in fiscal year 2025, with a net profit margin of 23.6%.
What is Corpay's EBITDA?
Corpay (CPAY) had EBITDA of $2.4B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Corpay have?
As of fiscal year 2025, Corpay (CPAY) had $2.4B in cash and equivalents against $10.0B in long-term debt.
What is Corpay's operating margin?
Corpay (CPAY) had an operating margin of 44.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Corpay's net profit margin?
Corpay (CPAY) had a net profit margin of 23.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Corpay's return on equity (ROE)?
Corpay (CPAY) has a return on equity of 27.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Corpay's free cash flow?
Corpay (CPAY) generated $1.3B in free cash flow during fiscal year 2025. This represents a -26.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Corpay's operating cash flow?
Corpay (CPAY) generated $1.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Corpay's total assets?
Corpay (CPAY) had $26.4B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Corpay's capital expenditures?
Corpay (CPAY) invested $200.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Corpay's current ratio?
Corpay (CPAY) had a current ratio of 0.98 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Corpay's debt-to-equity ratio?
Corpay (CPAY) had a debt-to-equity ratio of 2.58 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Corpay's return on assets (ROA)?
Corpay (CPAY) had a return on assets of 4.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Corpay's Altman Z-Score?
Corpay (CPAY) has an Altman Z-Score of 1.68, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Corpay's Piotroski F-Score?
Corpay (CPAY) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Corpay's earnings high quality?
Corpay (CPAY) has an earnings quality ratio of 1.40x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Corpay cover its interest payments?
Corpay (CPAY) has an interest coverage ratio of 4.94x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Corpay?
Corpay (CPAY) scores 64 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.